Wall Street analysts forecast that Henry Schein (HSIC) will report quarterly earnings of $0.99 per share in its upcoming release, pointing to a year-over-year decline of 18.2%. It is anticipated that revenues will amount to $3.23 billion, exhibiting an increase of 5.5% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior ...

Henry Schein, Inc. (HSIC) is expected to release first-quarter 2024 results on May 7 before the opening bell.The company posted adjusted earnings per share (EPS) of 66 cents in the last reported quarter, which missed the Zacks Consensus Estimate by 5.71%. In the trailing four quarters, Henry Schein’s earnings matched estimates once, surpassed once and missed in two quarters. The average negative surprise is 0.83%.Let’s see how things have shaped up prior to this announcement.Factors at PlayHealth Care Distr ...

Henry Schein (HSIC) is well-positioned to gain from its extensive global foothold and diverse channel mix. However, unfavorable currency movement and global economic uncertainties continue to affect the business. The stock carries a Zacks Rank #3 (Hold) currently.Henry Schein’s business boasts a broad global footprint with 61 distribution centers. Apart from North America, the company has a presence in Australia and New Zealand as well as in emerging nations like China, Brazil, Israel, the Czech Republic an ...

Henry Schein, Inc. (HSIC) is poised to experience growth in the coming quarters, backed by its encouraging strategy to expand digital dentistry globally. Niche acquisitions and partnerships have consistently fueled the company's revenue growth. Further, Henry Schein is upbeat about its dental technology joint venture (JV), Henry Schein One, which has been progressing well despite a challenging business environment.Meanwhile, the impact of the cybersecurity incident on HSIC’s operations remains concerning. M ...

Henry Schein, Inc. (HSIC) has recently completed the acquisition of orthopedic player TriMed for an undisclosed financial term. Integration of TriMed’s business will help the company to provide a wider range of surgical solutions to the existing Integrated Delivery Networks and Ambulatory Surgery Center customers. This will strengthen HSIC’s long-standing relationship with them.Headquartered in Santa Clarita, CA, TriMed is a global developer of solutions for the orthopedic treatment of lower extremities (fo ...

Henry Schein to Maximize Viome's Reach Among Dental and Medical Practices With Patient-Centric and Preventive Models of Care BELLEVUE, Wash., April 2, 2024 /PRNewswire/ -- Viome, a leading innovator of health technology and personalized health solutions, is partnering with Henry Schein to provide better access to Viome's Oral Health Pro™ With CancerDetect™.* Viome's laboratory-developed test* helps detect early biomarkers of oral and throat cancers, enhancing practitioners' ability to effectively harness th ...

Henry Schein has been recognized since 2012 and is one of only two honorees in the Healthcare Products industry. (Graphic: Business Wire)Henry Schein has been recognized since 2012 and is one of only two honorees in the Healthcare Products industry. (Graphic: Business Wire)MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, has received the 2024 World’s Most Ethical Companies® recognition ...

ZHENRY SCHEIN® Q4 2023 Earnings Conference Call Financial Results & Outlook | --- | --- | |------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Objective | Update | | | • Signed TriMed acquisition to ent ...

Henry Schein, Inc. (NASDAQ:HSIC) Q4 2023 Earnings Conference Call February 27, 2024 10:00 AM ET Company Participants Graham Stanley – Vice President, Investor Relations and Strategic Financial Project Officer Stanley Bergman – Chairman and Chief Executive Officer Ron South – Senior Vice President and Chief Financial Officer Conference Call Participants Elizabeth Anderson – Evercore ISI Jason Bednar – Piper Sandler John Stansel – JPMorgan Chase & Company Jon Block – Stifel Jeff Johnson – Baird Michael Cherny ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) Commission file number 0-27078 HENRY SCHEIN, INC. (Exact name of registrant as specified in its charter) Delaware 11-3136595 incorporation or organization) (State or other jurisdiction of (I.R.S. Employer Identification No.) 135 Duryea Road Melville, New York (Address of principal executive offices) 11747 (Zip Code) (631) 843-5500 (Registrant's telephone number, including area code) Securities registered pursuant to ...